ZIMV241220P12500
- 1.20
- 0.000.00%
ZimVie Newsroom
ZimVie Inc (ZIMV) Gets a Sell From Barclays
Earnings Call: ZimVie Reports Steady Growth and Improved Margins in Q3
Needham Maintains ZimVie(ZIMV.US) With Buy Rating, Maintains Target Price $23
ZimVie (ZIMV) Q3 2024 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript Summary
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
Earnings Flash (ZIMV) ZIMVIE Reports Q3 Revenue $103.2M
Express News | ZimVie Inc -Sees FY Net Sales $450 Mln to $455 Mln
ZimVie | 10-Q: Q3 2024 Earnings Report
ZimVie | 8-K: ZimVie Reports Third Quarter 2024 Financial Results
GUIDANCE: (ZIMV) ZIMVIE Expects Fiscal Year 2024 EPS Range $0.57 - $0.62
Express News | ZimVie Q3 Adjusted EPS USD 0.12
ZimVie to Present at the UBS Global Healthcare Conference
Uncovering Potential: ZimVie's Earnings Preview
Earnings Preview: ZimVie to Report Financial Results Post-market on October 30
ZimVie to Report Third Quarter Financial Results on October 30, 2024
Global Dental Implant Market Report and Company Analysis 2024-2032 Featuring Danaher, Dentsply Sirona, Institut Straumann, Zimmer Biomet, Kyocera, Henry Schein, Biocon, and Osstem Implant - ResearchAndMarkets.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Neuberger Berman Group LLC's Strategic Acquisition in ZimVie Inc
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, With Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes